Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia

Br J Haematol. 2011 Mar;152(5):623-30. doi: 10.1111/j.1365-2141.2010.08554.x. Epub 2011 Jan 17.

Abstract

The frequency and causes of treatment-related deaths (TRD) in second complete remission (CR2) in acute myeloid leukaemia (AML) were investigated in a historical, prospective cohort study of 429 children included in the Nordic Society of Paediatric Haematology and Oncology (NOPHO)-AML-88 and -93 trials. Relapse occurred in 158 children (39%). Seventeen (18%) of the 96 patients entering CR2 suffered TRD. The main causes were infection (59%) and complications from graft-versus-host disease (22%). Fourteen (82%) of 17 TRDs occurred in children undergoing haematopoietic stem cell transplantations (HSCT). Optimal supportive care after HSCT is essential, and studies on risk factors for TRD are needed.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Child
  • Child, Preschool
  • Disease Progression
  • Epidemiologic Methods
  • Female
  • Graft vs Host Disease / mortality
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Male
  • Opportunistic Infections / mortality
  • Recurrence
  • Remission Induction
  • Scandinavian and Nordic Countries / epidemiology